Management Team

Joan Robbins, PhD

vice president, Translational research

Joan Robbins has comprehensive experience in the development of gene therapy. Prior to joining DNAtrix, Joan served as Senior Vice President of Biosafety & Gene Therapy at Western Institutional Review Board (WIRB) - Copernicus Group, the world’s largest provider of regulatory and ethical review for human research. Prior to that she was Vice President of Translational Research at Tocagen, advancing the first replicating retroviral vector from the bench to a pivotal study in primary brain cancer. She also served as CSO of ADVENTRX Pharmaceuticals, developing a portfolio of drugs for cancer and infectious disease, and was VP of Product Development at Immusol, developing gene therapies and biologics for multiple indications. Additionally, Joan is the co- founder of two virus and biologic specialty manufacturing companies. Joan trained at the NIH/NCI, the Garvan Institute and Center for Immunology (Sydney, Australia), and the University of California, San Diego. She received a BS in Genetics from the University of California, Davis, and a PhD in Genetics from the George Washington University, Washington, D.C.

Ken Bright

Corporate Controller

Ken Bright has over 10 years of senior management experience in the pharmaceuticals, diagnostics, and life science research tools industries as both a corporate controller and advisor. Ken brings broad experience in accounting and financial reporting for publicly traded and private companies. Ken received a BA in Business Economics from University of California Santa Barbara and holds an inactive CPA license in the state of California.